Previous 10 | Next 10 |
Dry wipes are specifically designed for applying Avenova ® to treat dry eye and blepharitis NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces the launch of NovaWipes , a dry, soft, hypoallergenic and absorbable wipe for use in applying Avenova ® , on A...
The market is vast with many different options for investors to put money into. You can trade anything from penny stocks to large-cap stocks. When it comes to penny stocks, these are considered to be any equity that trades below $5. The cheap stocks can bring investors large amounts of profits...
NovaBay Pharmaceuticals (NYSEMKT: NBY ) is up 21% premarket after the launch of NovaSight, a proprietary daily vitamin and mineral supplement specially formulated to support ocular health, on Amazon.com. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks...
NovaSight complements Avenova ® Direct for comprehensive internal and external eye health NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces the launch of NovaSight ™, a proprietary daily vitamin and mineral supplement specially formulated to support o...
NovaBay Pharmaceuticals, Inc. (NBY) Q3 2019 Results Conference Call November 07, 2019 04:30 PM ET Company Participants Jody Cain - Investor Relations Justin Hall - President and Chief Executive Officer Jason Raleigh - Chief Financial Officer Conference Call Participants Jef...
NovaBay (NYSEMKT: NBY ): Q3 GAAP EPS of -$0.02 beats by $0.06 . More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
Conference call begins at 4:30 p.m. Eastern time today NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, reports financial results for the three and nine months ended...
Prescription-strength CelleRx to gently clean skin and ease post-procedure discomfort is now available without a prescription at www.CelleRx.com NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces the availability of full-strength CelleRx for consumer purchase with...
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that it will report third quarter 2019 financial results after market close on Thursday, November 7, 2019 and will ...
Once-daily system complements Avenova and leverages salesforce calls on eyecare specialists NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces an exclusive 90-...
News, Short Squeeze, Breakout and More Instantly...
NovaBay Pharmaceuticals Inc. Company Name:
NBY Stock Symbol:
NYSE Market:
NovaBay Pharmaceuticals Inc. Website:
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reports record sales of Avenova ® -branded eyecare products during the Amazon Prime Day event, which was held July 16-17, 2024. Over the two-day period, Avenova sales were 17% higher compared with Prime Day 2023 and were up 40% over ...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series F-1 warrants, Series F-2 warrants and Series F-3 warrants f...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, July 26, 2024 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“ NioBay ” or the “ Company ”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce th...